Hologic, Inc. (HOLX)
NASDAQ: HOLX · Real-Time Price · USD
64.33
+1.26 (2.00%)
Jun 6, 2025, 4:00 PM - Market closed
Hologic Employees
Hologic had 6,990 employees as of September 30, 2023. The number of employees increased by 46 or 0.66% compared to the previous year.
Employees
6,990
Change (1Y)
46
Growth (1Y)
0.66%
Revenue / Employee
$576,037
Profits / Employee
$79,642
Market Cap
14.34B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Sep 30, 2023 | 6,990 | 46 | 0.66% |
Sep 24, 2022 | 6,944 | 239 | 3.56% |
Sep 25, 2021 | 6,705 | 891 | 15.33% |
Sep 26, 2020 | 5,814 | -664 | -10.25% |
Sep 28, 2019 | 6,478 | 226 | 3.61% |
Sep 29, 2018 | 6,252 | 19 | 0.30% |
Sep 30, 2017 | 6,233 | 900 | 16.88% |
Sep 24, 2016 | 5,333 | 43 | 0.81% |
Sep 26, 2015 | 5,290 | -61 | -1.14% |
Sep 27, 2014 | 5,351 | -264 | -4.70% |
Sep 28, 2013 | 5,615 | -542 | -8.80% |
Sep 29, 2012 | 6,157 | 1,138 | 22.67% |
Sep 24, 2011 | 5,019 | 799 | 18.93% |
Sep 25, 2010 | 4,220 | 261 | 6.59% |
Sep 26, 2009 | 3,959 | 26 | 0.66% |
Oct 25, 2008 | 3,933 | 353 | 9.86% |
Nov 12, 2007 | 3,580 | 1,963 | 121.40% |
Nov 17, 2006 | 1,617 | 747 | 85.86% |
Nov 19, 2005 | 870 | 109 | 14.32% |
Nov 30, 2004 | 761 | 39 | 5.40% |
Nov 30, 2003 | 722 | -7 | -0.96% |
Nov 30, 2002 | 729 | -51 | -6.54% |
Nov 30, 2001 | 780 | -66 | -7.80% |
Nov 30, 2000 | 846 | 410 | 94.04% |
Nov 30, 1999 | 436 | 40 | 10.10% |
Nov 30, 1998 | 396 | 57 | 16.81% |
Nov 30, 1997 | 339 | 45 | 15.31% |
Nov 30, 1996 | 294 | 103 | 53.93% |
Nov 30, 1995 | 191 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
HOLX News
- 6 days ago - Hologic Joins NEST Governance Committee to Advance the Use of Real-World Data in Medical Device Evaluation - Business Wire
- 12 days ago - Why Is Diagnostic Firm Hologic Stock Trading Higher On Tuesday? - Benzinga
- 12 days ago - Hologic rejects $16 billion take-private proposal from TPG and Blackstone, Financial Times reports - Reuters
- 17 days ago - Hologic to Present New Data at ASCO 2025 Reinforcing the Practice-Changing Role of the Breast Cancer Index® Test in Helping to Deliver More Personalized Care to Patients - Business Wire
- 26 days ago - Hologic to Webcast Presentations at Upcoming Investor Conferences - Business Wire
- 4 weeks ago - Hologic: Soft Performance, But Cheap Enough - Seeking Alpha
- 5 weeks ago - Hologic, Inc. (HOLX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Medical equipment maker Hologic lowers annual profit forecast on tariff uncertainty - Reuters